CGM Systems P3

Continuous glucose monitoring system for real-time blood glucose tracking in diabetes management. The wearable CGM device provides automated glucose readings and trend analysis, enabling patients and clinicians to optimize insulin therapy and glycemic control. Features wireless connectivity and cloud-based data management for remote patient monitoring.

A continuous glucose monitoring system that tracks blood glucose levels in real-time for 14 days without fingerstick testing. Data can be viewed on smartphones and smartwatches and shared remotely with family members and hospital systems for better blood sugar health management.

A wearable continuous glucose monitoring device that monitors interstitial glucose levels for up to 14 days. Paired with a mobile app, it helps patients with type 1, type 2, or gestational diabetes understand glucose trends and optimize treatment and lifestyle decisions.

A wearable smart blood glucose monitoring system with 14-day continuous wear capability. The device integrates with mobile applications and smartwatches to provide real-time glucose data and trend analysis for diabetes management.

Innovative continuous glucose monitoring systems for precise blood glucose management. These devices provide ongoing glucose monitoring capabilities backed by 480+ core CGM patents and advanced hardware-software integration.

A calibration-free continuous glucose monitoring system designed for patients with Type 1 or Type 2 Diabetes Mellitus. The system features a wearable sensor that lasts 14 days, requires no scanning, and provides glucose readings updated every 5 minutes via Bluetooth. It is waterproof and can be worn while bathing, showering, swimming, or exercising. The system includes a smartphone app for iOS and Android that stores glucose data and generates Ambulatory Glucose Profile (AGP) reports, with CE MDR certification obtained in 2023.

A continuous glucose monitoring (CGM) system intended for patients 3 years and older with Type 1 or Type 2 Diabetes Mellitus in select countries, and 18 years and older in other countries. The system includes a wearable sensor and display device that communicate via Bluetooth within 6 meters, with glucose readings updated every 5 minutes after a 1-hour warm-up period. The sensor is water-resistant and can be worn while bathing, showering, or swimming (up to 1 meter depth for 1 hour maximum). The system stores the last 90 days of glucose data and supports mobile app connectivity for glucose monitoring and trending analysis.

Wearable continuous glucose monitoring device for real-time blood glucose tracking and glucose trend analysis in diabetes management.

A wearable continuous glucose monitoring system providing real-time glucose readings every 5 minutes for 14 days. The device features calibration-free operation, automatic data transmission via Bluetooth, and IP28 waterproof rating. EU MDR CE certified for clinical use in glucose management.

The SIBIONICS GS1 is a wearable continuous glucose monitoring (CGM) system that provides real-time glucose readings for 14 days without calibration, scanning, or fingerstick testing. Designed for diabetes management, the sensor delivers industry-leading accuracy and is waterproof for continuous wear on the upper arm. The system connects to a mobile app for glucose trend tracking and alerts.

A continuous glucose monitoring (CGM) system intended for patients 3 years and older with Type 1 or Type 2 Diabetes Mellitus in select countries, and 18 years and older in other countries. The system includes a wearable sensor and display device that communicate via Bluetooth within 6 meters, with glucose readings updated every 5 minutes after a 1-hour warm-up period. The sensor is water-resistant and can be worn while bathing, showering, or swimming (up to 1 meter depth for 1 hour maximum). The system achieves a MARD accuracy of 8.7% in children and adolescents aged 3-17 and 8.83% in adults 18 and older.

A comprehensive blood glucose management solution based on continuous glucose monitoring (CGM) technology that provides real-time glucose data display, storage, and transmission throughout the entire process. The system supports multiple clinical scenarios including outpatient departments, wards, homes, and nursing facilities, and facilitates remote monitoring and guidance for diabetes management across hospital and community settings.